PMID- 22096508 OWN - NLM STAT- MEDLINE DCOM- 20120410 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 6 IP - 11 DP - 2011 TI - Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1. PG - e26949 LID - 10.1371/journal.pone.0026949 [doi] LID - e26949 AB - Genetic variations in human leukocyte antigens (HLA) are critical in host responses to infections, transplantation, and immunological diseases. We previously identified associations with non-Hodgkin lymphoma (NHL) and the HLA-DRB1*01:01 allele and extended ancestral haplotype (AH) 8.1 (HLA-A*01-B*08-DR*03-TNF-308A). To illuminate how HLA alleles and haplotypes may influence NHL etiology, we examined potential interactions between HLA-DRB1*01:01 and AH 8.1, and a wide range of NHL risk factors among 685 NHL cases and 646 controls from a United States population-based case-control study. We calculated odds ratios and 95% confidence intervals by HLA allele or haplotype status, adjusted for sex, age, race and study center for NHL and two major subtypes using polychotomous unconditional logistic regression models. The previously reported elevation in NHL risk associated with exposures to termite treatment and polychlorinated biphenyls were restricted to individuals who did not possess HLA-DRB1*01:01. Previous associations for NHL and DLBCL with decreased sun exposure, higher BMI, and autoimmune conditions were statistically significant only among those with AH 8.1, and null among those without AH 8.1. Our results suggest that NHL risk factors vary in their association based on HLA-DRB1*01:01 and AH 8.1 status. Our results further suggest that certain NHL risk factors may act through a common mechanism to alter NHL risk. Finally, control participants with either HLA-DRB1*01:01 or AH 8.1 reported having a family history of NHL twice as likely as those who did not have either allele or haplotype, providing the first empirical evidence that HLA associations may explain some of the well-established relationship between family history and NHL risk. FAU - Wang, Sophia S AU - Wang SS AD - Division of Cancer Etiology, Department of Population Sciences, Beckman Research Institute and City of Hope, Duarte, California, United States of America. sowang@coh.org FAU - Lu, Yani AU - Lu Y FAU - Rothman, Nathaniel AU - Rothman N FAU - Abdou, Amr M AU - Abdou AM FAU - Cerhan, James R AU - Cerhan JR FAU - De Roos, Anneclaire AU - De Roos A FAU - Davis, Scott AU - Davis S FAU - Severson, Richard K AU - Severson RK FAU - Cozen, Wendy AU - Cozen W FAU - Chanock, Stephen J AU - Chanock SJ FAU - Bernstein, Leslie AU - Bernstein L FAU - Morton, Lindsay M AU - Morton LM FAU - Hartge, Patricia AU - Hartge P LA - eng GR - N01 PC067010/PC/NCI NIH HHS/United States GR - N01 PC067008/PC/NCI NIH HHS/United States GR - N01-PC-67009/PC/NCI NIH HHS/United States GR - N01 PC065064/PC/NCI NIH HHS/United States GR - ImNIH/Intramural NIH HHS/United States GR - HHSN261200800001C/RC/CCR NIH HHS/United States GR - HHSN261200800001E/CA/NCI NIH HHS/United States GR - N01 PC067009/CN/NCI NIH HHS/United States GR - N02-PC-71105/PC/NCI NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, N.I.H., Intramural DEP - 20111109 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (HLA-DRB1 Chains) SB - IM MH - Adult MH - Aged MH - Alleles MH - Confidence Intervals MH - Female MH - Genotype MH - HLA-DRB1 Chains/*genetics MH - Haplotypes/*genetics MH - Humans MH - Lymphoma, Non-Hodgkin/*genetics MH - Male MH - Middle Aged MH - Risk Factors MH - Young Adult PMC - PMC3212525 COIS- Competing Interests: The authors have read the journal's policy and have the following conflicts: Co-author completed part of this study while employed at SAIC Frederick Inc. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials, as detailed online in the guide for authors. EDAT- 2011/11/19 06:00 MHDA- 2012/04/11 06:00 PMCR- 2011/11/09 CRDT- 2011/11/19 06:00 PHST- 2011/07/06 00:00 [received] PHST- 2011/10/06 00:00 [accepted] PHST- 2011/11/19 06:00 [entrez] PHST- 2011/11/19 06:00 [pubmed] PHST- 2012/04/11 06:00 [medline] PHST- 2011/11/09 00:00 [pmc-release] AID - PONE-D-11-12868 [pii] AID - 10.1371/journal.pone.0026949 [doi] PST - ppublish SO - PLoS One. 2011;6(11):e26949. doi: 10.1371/journal.pone.0026949. Epub 2011 Nov 9.